Results 191 to 200 of about 30,100 (305)

Endocrine manifestations of Luscan-Lumish syndrome associated with a novel SETD2 frameshift variant. [PDF]

JCEM Case Rep
Huang J, Ashouri D, Dominguez AL.
europepmc   +1 more source

An Action of Gonadotropin in Vitro

Journal of Biological Chemistry, 1961
N R, MASON, J M, MARSH, K, SAVARD
openaire   +3 more sources

Hormonal Therapy Before Micro‐TESE in Men With Nonobstructive Azoospermia: A Negative Answer to an Overly Broad Question

Andrology, EarlyView.
Sandro C. Esteves, Arnold P. P. Achermann, Ricardo Miyaoka, Cassio L. Z. Riccetto, Adriano Fregonesi   +4 more
wiley   +1 more source

Higher LSD1 in Non‐Seminomatous Germ Cell Tumors and LSD1 Inhibition by NCL1 Suppresses Embryonal Carcinoma Growth

Cancer Science, EarlyView.
LSD1 expression was higher in non‐seminomatous than in seminomatous testicular germ cell tumor components. In embryonal carcinoma models, selective LSD1 inhibition by NCL1 induced epigenetic and apoptotic responses, reduced viability including in cisplatin‐adapted cells, and suppressed early xenograft outgrowth, supporting LSD1 as a potential ...
Nobuhiko Shimizu, Toshiki Etani, Taku Naiki, Aya Naiki‐Ito, Yosuke Sugiyama, Takashi Nagai, Akihiro Murakami, Hiroyuki Kato, Toshiharu Morikawa, Maria Aoki, Masakazu Gonda, Hiroko Suzuki, Yohei Tsubouchi, Daiki Ishikawa, Takayoshi Suzuki, Satoru Takahashi, Takahiro Yasui   +16 more
wiley   +1 more source

The extragonadal biology of gonadotropin hormones: should we rename these? [PDF]

Endocr Connect
Kim SM, Korkmaz F, Kang S, Sen F, Sims SL, Gimenez-Roig J, Cheliadinova U, Vasilyeva D, Barak O, Hutchison S, Macdonald A, Latif R, Goosens K, Frolinger T, Pallapati A, Rojekar S, Ryu V, Lizneva D, Yuen T, Zaidi M.   +19 more
europepmc   +1 more source

Session 33 – Gonadotropins and gonadotropin receptors [PDF]

Human Reproduction, 2005
openaire   +1 more source

Author's Response: Can Hormonal Therapy Improve the Outcomes of mTESE in Patients with Nonobstructive Azoospermia?

Andrology, EarlyView.
M. Anfosso, M. Schubert, JF. Cremers, S. Kliesch, M. Zitzmann, S. Bier   +5 more
wiley   +1 more source

Pubertal Dynamics of Sertoli and Leydig Cell Dysfunction in Klinefelter Syndrome

Clinical Endocrinology, EarlyView.
ABSTRACT Context Klinefelter syndrome (KS), defined by a 47, XXY karyotype, is commonly associated with progressive testicular failure. The precise timing of Sertoli and Leydig cell dysfunction during puberty remains unclear. Objective To determine the onset and progression of testicular insufficiency during puberty in KS, and to assess whether ...
Tredez Axelle, Christine Lefevre, Simon Boussion, Cindy Colson, Iva Gueorguieva, Francois Marcelli, Anne Laure Barbotin, Pascal Pigny, Hamza Benderradji, Clara Leroy   +9 more
wiley   +1 more source

A dynamic "hormonal tug-of-war" driven by a functioning ovarian remnant after testis-preserving partial gonadectomy in ovotesticular disorders of sex development: a case report. [PDF]

Clin Pediatr Endocrinol
Johnin K, Matsui K, Moritani S, Chatani S, Itoh R, Mori Y, Nakagawa S, Kobayashi K, Yoshida T, Kageyama S.   +9 more
europepmc   +1 more source

Current Approaches to Support Patients to Withdraw From Image and Performance Enhancing Drugs

Clinical Endocrinology, EarlyView.
ABSTRACT Image and performance‐enhancing drugs (IPEDs) include agents such as androgens, growth hormone, and erythropoietin, which are used to enhance appearance and physical performance. Androgens, also known as anabolic‐androgenic steroids (AAS), are the most used IPEDs worldwide.
Elizabeth Hyams, Bonnie Grant, Richard Quinton, Channa N. Jayasena   +3 more
wiley   +1 more source